We are live on ! Find out more
CRBP icon

Corbus Pharmaceuticals
CRBP

54 hedge funds and large institutions have $116M invested in Corbus Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

10% more funds holding

Funds holding: 49 → 54 (+5)

5% more capital invested

Capital invested by funds: $110M → $116M (+$5.59M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.02% less ownership

Funds ownership: 0.98% → 0.96% (-0.02%)

23% less call options, than puts

Call options by funds: $7.59M | Put options by funds: $9.83M

Holders
54
Holders Change
+5
Holders Change %
+10.2%
% of All Funds
1.34%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
21
Reduced
10
Closed
8
Calls
$7.59M
Puts
$9.83M
Net Calls
-$2.25M
Net Calls Change
+$686K

Top Buyers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
+$9.61M
2
BlackRock
BlackRock
New York
+$5.44M
3
IA
IFP Advisors
Florida
+$3.89M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.34M
5
VKH
Virtu KCG Holdings
New York
+$1.06M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$6.66M
2
EI
EAM Investors
California
-$1.36M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.29M
4
BBA
Baker Bros. Advisors
New York
-$1.06M
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$854K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$345K -$98.2K -400 -22%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$289K – – –
HSBC Holdings
28
HSBC Holdings
United Kingdom
$288K +$285K +1,162 New
VEA
29
Virtus ETF Advisers
New York
$268K +$25.5K +104 +11%
BCM
30
BlueCrest Capital Management
Jersey
$246K +$244K +994 New
GP
31
GLG Partners
United Kingdom
$226K +$224K +913 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$174K +$12.3K +50 +8%
EAM
33
Evanson Asset Management
California
$168K +$2.94K +12 +2%
CS
34
Credit Suisse
Switzerland
$157K +$155K +633 New
State Street
35
State Street
Massachusetts
$156K -$3.44K -14 -2%
Citadel Advisors
36
Citadel Advisors
Florida
$148K +$147K +597 New
SG Americas Securities
37
SG Americas Securities
New York
$148K +$147K +598 New
PAG
38
Private Advisor Group
New Jersey
$140K -$57.2K -233 -28%
QT
39
Quantbot Technologies
New York
$114K +$114K +463 New
IIA
40
IPG Investment Advisors
California
$109K +$108K +442 New
Verition Fund Management
41
Verition Fund Management
Connecticut
$108K +$107K +436 New
CG
42
Cutler Group
California
$56K -$48.1K -196 -46%
AG
43
Advisor Group
Arizona
$35K +$9.33K +38 +38%
FPF
44
FNY Partners Fund
New York
$33K +$16.2K +66 +99%
LTFS
45
Ladenburg Thalmann Financial Services
Florida
$32K +$4.17K +17 +15%
Wells Fargo
46
Wells Fargo
California
$22K +$9.82K +40 +80%
Citigroup
47
Citigroup
New York
$13K +$13K +53 New
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$10K – – –
UBS Group
49
UBS Group
Switzerland
$9K +$1.23K +5 +15%
US Bancorp
50
US Bancorp
Minnesota
$7K +$6.63K +27 New
1
2
3

CRBP Hedge Fund Activity: Q1 2017 in Review

54 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q1 2017, worth a combined $116M — up 5.1% from $110M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CRBP positions and 8 closed out — a net gain of 10 holders — while 21 added to existing stakes and 10 trimmed.

The largest buyer was Knoll Capital Management, adding an estimated $9.61M. The largest seller was Cormorant Asset Management, cutting an estimated $6.66M.

  • 54 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q1 2017, up from 49 in Q4 2016.
  • Funds reported $116M of Corbus Pharmaceuticals stock for Q1 2017, up 5.1% quarter-over-quarter.
  • 18 funds opened new Corbus Pharmaceuticals positions in Q1 2017 and 8 closed out, a net change of +10 holders.
  • The largest Corbus Pharmaceuticals buyer in Q1 2017 was Knoll Capital Management, an estimated $9.61M added.
  • The largest Corbus Pharmaceuticals seller in Q1 2017 was Cormorant Asset Management, an estimated $6.66M sold.

Based on aggregated 13F filings for Q1 2017.